Navigation Links
Results From Phase 3 EQUATE Trial of VIVUS' Qnexa Highlighted at European Congress on Obesity
Date:5/7/2009

centage of subjects achieving a weight loss of five percent or more. In total, the phase 3 program has enrolled approximately 4,500 patients.

Results from these studies are expected in the third quarter of 2009.

About EQUATE

The EQUATE study included 756 obese patients (599 females and 157 males) across 32 centers in the United States. The average baseline BMI of the study population was 36.3 kg/m2 and baseline weight was 101.3 kg. The study was a randomized, double-blind, placebo-controlled, prospective trial with subjects randomized to receive once-a-day treatment with mid-dose Qnexa (7.5 mg phentermine/46 mg topiramate CR), full-dose Qnexa (15 mg phentermine/92 mg topiramate CR), the respective phentermine and controlled-release topiramate constituents, or placebo. Patients had a four-week dose titration period followed by 24 weeks of treatment. Subjects were asked to follow a hypocaloric diet representing a 500-calorie/day deficit and advised to implement a simple lifestyle modification program.

About Obesity

More than 300 million people worldwide and approximately 30 percent of American adults (more than 60 million people) are obese, a chronic condition defined by having excess body fat. As the second leading cause of preventable death, obesity directly contributes to numerous life-threatening conditions including diabetes, cardiovascular disease, hypertension and stroke. Experts agree that even a modest weight loss of five percent of weight, maintained over time, can bring significant health benefits by lowering blood pressure and reducing the risk of diabetes and heart disease.

About Qnexa(TM)

Qnexa (Q-NEX-uh) is a proprietary, low dose, controlled release formulation of phentermine and topiramate that simultaneously addresses both appetite and satiety - the two main mechanisms that impact eatin
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
2. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
3. Transcept Pharmaceuticals to Report First Quarter 2009 Results
4. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
5. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
6. Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
7. Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer
8. Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
9. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
10. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
11. Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC announces ... Lafayette, Indiana , has enhanced its capabilities ... of small and large molecules, including biologic drugs, ... Bruker maXisPlus Q-TOF mass spectrometer. In ... CEO, Aptuit, said, "The expanded large molecule capability ...
(Date:8/21/2014)... , Aug. 21, 2014   Memorial Hermann Health System ... Center today announced a new partnership to provide a ... community breast care centers in the greater Houston ... Anderson will become the exclusive provider of professional breast radiology ... located in Memorial City, The Woodlands , ...
(Date:8/21/2014)... 21, 2014  Vermillion, Inc. (NASDAQ: VRML ... and women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record ... for laboratory services companies. She has more than 20 ... where she held the position of Director, Lab Services ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... 25, 2007 /PRNewswire-FirstCall/ --,Genaera Corporation today announced ... (MSI-1436) for the treatment of obesity were,presented ... Sessions, June 22-25 in Chicago, IL. Dr. ... of Abstract #1801-P,presented, "Trodusquemine is a Multiple ...
... 25, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today ... trial evaluating the company's once-daily,anti-HIV drug Viread(R) ... as a potential treatment for chronic hepatitis ... endpoint. The data show,that Viread is non-inferior ...
Cached Medicine Technology:Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
(Date:8/22/2014)... The rising numbers of teen drug and ... NC. For many years, countless lives have been lost due ... the community a new helpline was established to provide a ... Carolina who are seeking to overcome their addiction issues. ... 348-5762, parents and their teens can speak immediately to a ...
(Date:8/22/2014)... Teen substance abuse has long been a major ... of young adults falling victim to a drug or ... difference in the community, the new Troubled Teens Toledo helpline ... to overcome their chemical dependency. The helpline is designed to ... center to focus on achieving sobriety. , By contacting the ...
(Date:8/22/2014)... Teen substance abuse has long been major issue ... adults never receive the professional treatment they need. To ... Troubled Teens Columbus helpline was established to provide a ... and alcohol dependencies . , By calling ... can speak directly to a representative who can offer ...
(Date:8/22/2014)... Dealing with a drug or alcohol addiction is never ... child. Adolescent substance abuse has been an important issue among ... new helpline is now providing a valuable resource for teens ... like a teen drug addiction . , The ... positive impact in the community. By calling (513) 318-1603, parents ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Drug and ... Ohio. Over the years, substance abuse has claimed thousands ... in Brunswick, OH is providing hope for teenagers who ... Teens Brunswick helpline is designed to provide adolescents and ... where to find the best youth rehab facility to ...
Breaking Medicine News(10 mins):Health News:Troubled Teens in Asheville, NC Turn to Helpline for Valuable Assistance 2Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2
... residents,neuroscience researchers, and interested clinicians will each have,opportunities ... of stroke during the Texas Brain and Spine ... year,s symposium will consist of a,morning presentation for ... researchers. The speakers are both neuroscience specialists who ...
... online community, for people who support affordable health insurance options ... ... While politicians dispense,their health care ideas at party conventions and ... common place to do so is at,AffordableHealthInsurance.NET -- a new social ...
... Lance Armstrong, cancer,survivor, founder and chairman of the Lance ... regarding his return to,professional sports:, "I am happy ... family,and my closest friends, I have decided to return ... global cancer burden. This year alone,nearly eight million people ...
... Pa., Sept. 9 Encorium Group, Inc.,(Nasdaq: ... organization,(CRO) conducting studies in over 30 countries for ... today announced that it,has entered into an amendment ... Research International, Inc. ("Prologue"). Pursuant to the,Amendment, the ...
... women between the ages of 40 and 59 could substantially ... in the September 9 online issue of the Journal ... programs are regularly used in developed countries where the incidence ... system is in place. The value and practicality of such ...
... A narrow region on chromosome 15 contains genetic variations ... conducted by scientists at Washington University School of Medicine ... States and the United Kingdom. , The researchers found ... cancer for people who have both a family history ...
Cached Medicine News:Health News:Texas Brain and Spine Institute to Hold Second Annual Neuroscience Symposium 2Health News:Social Network for Affordable Health Care Supporters Stimulates a New Level of Interactivity and Dialogue 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 3Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 4Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 5Health News:Breast cancer screening may lower mortality and disease burden in India 2Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3
... engineered to set a new standard for ... enter the patient demographics, select auto report ... based system uses the latest in software ... of the IQmark Holter algorithm. Simple, intuitive ...
... your patients' remarkable skin Transformation in less than ... common alpha-hydroxy peels or other superficial procedures, the ... hands - yours. Based on your patients' particular ... of Tricloracetic Acid (TCA) peels and number of ...
... Smoothie is deliciously refreshing scrub ... the use of a gentle ... exfoliate the skin to restore ... irritation. This light chemical peel ...
... rapid exfoliator. Lactic Acid is is recommended for ... agents in skin care products, as well as ... long period and want to improve results. ,Lactic ... combined with the chemical free style of Peel ...
Medicine Products: